NCT06291935RecruitingPhase 1/2
A trial in patients suffering from a specific form of an eye disorder called retinitis pigmentosa
Source: EU CTIS (euclinicaltrials.eu) · Last updated 4 Nov 2026
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1/2
- Study type
- Interventional
- Enrollment
- 6 (estimated)
- First submitted
- 6 Mar 2023
- Start date
- 2 Feb 2025
- Lead sponsor
- VeonGen Therapeutics GmbH
- Diseases
- Retinitis pigmentosa
- EU CT number
- 2023-504383-42-00
What you commit to
- Study type: Interventional · Phase 1/2
- Planned participants: 6
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ludwig-Maximilians-Universitaet Muenchen Coordinator of this site? Confirm its status | Munich | Germany | Recruiting |
| Universitaetsklinikum Tuebingen AöR Coordinator of this site? Confirm its status | Tuebingen | Germany | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.